Achilles Therapeutics plc (ACHL) Social Stream
ACHILLES THERAPEUTICS PLC (ACHL) Price Targets From Analysts
Use the tables below to see what analysts covering ACHILLES THERAPEUTICS PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 5 | $27 | $6 | $19 | $0.85 | 2135.29% |
| 2022-03-02 | 5 | $27 | $7 | $19.2 | $0.85 | 2158.82% |
| 2022-03-03 | 5 | $27 | $7 | $17.8 | $0.85 | 1994.12% |
| 2022-03-31 | 5 | $27 | $7 | $17.4 | $0.85 | 1947.06% |
| 2022-05-11 | 5 | $20 | $7 | $15.4 | $0.85 | 1711.76% |
| 2022-05-27 | 5 | $20 | $7 | $14.4 | $0.85 | 1594.12% |
| 2022-08-13 | 5 | $20 | $7 | $13 | $0.85 | 1429.41% |
| 2022-11-11 | 5 | $20 | $7 | $12.8 | $0.85 | 1405.88% |
| 2023-01-25 | 5 | $17 | $7 | $10 | $0.85 | 1076.47% |
| 2023-02-08 | 5 | $17 | $8 | $11 | $0.85 | 1194.12% |
| 2023-03-07 | 4 | $17 | $8 | $11 | $0.85 | 1194.12% |
| 2023-05-10 | 4 | $12 | $7 | $9 | $0.85 | 958.82% |
| 2023-05-16 | 4 | $11 | $7 | $8.666 | $0.85 | 919.53% |
| 2023-11-14 | 3 | $11 | $7 | $8.666 | $0.85 | 919.53% |
The Trend in the Analyst Price Target
Over the past 14 months, ACHL's average price target has gone down $4.13.
ACHL reports an average of 808.38% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 5 | 17 | 8 | 11.000 | 1.200 | 816.67% |
| 2023-02-08 | 4 | 17 | 8 | 11.000 | 1.200 | 816.67% |
| 2023-05-11 | 4 | 11 | 7 | 8.666 | 0.953 | 809.34% |
| 2023-05-16 | 4 | 11 | 7 | 8.666 | 1.000 | 766.6% |
| 2023-06-28 | 3 | 11 | 7 | 8.666 | 0.980 | 784.29% |
ACHL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 25 months, ACHL's average broker recommendation rating improved by 0.8.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ACHL has a higher upside potential (average analyst target price relative to current price) than 1461.92% of all US stocks.
- ACHL has a greater average analyst price target than 241.88% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ACHILLES THERAPEUTICS PLC's variance in analysts' estimates is lower than -1073.82% of them.
- In the context of Healthcare stocks, ACHILLES THERAPEUTICS PLC's number of analysts covering the stock is higher than 346.2% of them.
Stocks similar to ACHILLES THERAPEUTICS PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MOLN, IPSC, and AMAM.
View All Top Stocks by Price Target
What is the outlook for ACHL? Use POWR Ratings for clearer insight into price direction.